Prime Minister’s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund) has allocated ₹2,000 crore today for supply of 50,000 ventilators of Made-in-India by end of this month to all states and union territory, but Delhi and Maharashtra (worst-affected states due to COVID 19 pandemic in India) may get most. So far 2,923 ventilators have been manufactured, of which 1,340 ventilators have been delivered to the states/UTs. Out of the 50,000 ventilators, 30,000 are being manufactured by Bharat Electronics Ltd and the remaining by AgVa Healthcare (10,000), AMTZ Basic (5,650), AMTZ High End (4,000), and Allied Medical (350).
The distribution of the fund is based on the formula of 50% weightage for the population as per the 2011 census. Maharashtra (181 crores), Uttar Pradesh (103 crores), Tamil Nadu (83 crores), Gujarat (66 crores), and Delhi (55 crores) are some of the prominent recipients of this grant. The entire amount has already been released to the states and the Union territories. And 10% for equal distribution among all the states or Union territories under PM CARES Fund. India’s coronavirus caseload stands at 4,40,215, as per the latest health ministry update. The death toll stands at 14,011.
Meanwhile, Ramdev’s Patanjali launches the first Ayurvedic medicine today named Coronil kit for ₹545 to treat COVID-19. The medicine, made out of Ayurvedic herbs like ashwagandha and giloy claims to have a “100%” recovery rate. Acharya Balkrishna, MD of Patanjali Ayurved, claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 3-14 days.
Baba Ramdev also claims that there are no side-effects of the corona medicines he is launching. A total of 100 Coronavirus positive patients were recruited for the controlled clinical trial, Patanjali claims. Of which 95 were studied, 1 patient was lost on the follow-up details and 4 patients withdrew consent between the study, claims Patanjali.
Published: Hindustan View 23/06/2020